Body
New research from The University of Queensland has found that women who have hot flushes and night sweats after menopause are 70 per cent more likely to have heart attacks, angina and strokes.
School of Public Health PhD student Dr Dongshan Zhu has found women of any age who experience hot flushes and night sweats, also known as vasomotor symptoms or VMS, are more likely to experience non-fatal cardiovascular events.
"Until now, it's been unclear if VMS is associated with cardiovascular disease, but now we know it to be true," Dr Zhu said.
Better still: living algae can be used as biocatalysts for certain substances, and they bring the co-substrate along, producing it in an environmentally friendly manner through photosynthesis. The team published its report in Algal Research on 17. June 2020.
It's a question of 3D structure
Healing with the help of marine organisms is no utopia. Already 12 life-saving drugs, e.g. against cancer, have been developed from marine organisms and their symbiotic microbiota. Their high potential for drug development is hampered by the lengthy and costly discovery process.
New technique in which drugs make bacteria glow could help fight antibiotic resistance
A new technique could help reduce antibiotic prescribing by predicting which drugs could be effective in fighting bacteria within minutes.
WASHINGTON--Health care providers may unintentionally expose patients to endocrine- disrupting chemicals (EDCs) by prescribing certain medications and using medical supplies, according to a perspective published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
In a newly published experimental study, the consumption of dietary fibre from oat and rye brans supported the growth of beneficial gut microbiota, which in turn ameliorated cholesterol metabolism, enhanced gut barrier function and reduced hepatic inflammation. In addition, diets enriched with oat or rye bran were shown to attenuate weight gain. The effects of oat and rye were partly different, but both were beneficial for health.
Researchers at the University of Tasmania's Menzies Institute for Medical Research and the School of Medicine have added an arsenal of new tools (video link) to their repertoire for fighting the insidious Devil Facial Tumour Disease.
A paper published today in the prestigious Science Advances journal outlines new cost-effective technology that can be used for advanced immunology studies in Tasmanian devils.
What The Study Did: Researchers investigated the association between the stage of breast cancer at diagnosis and the insurance status, age and race/ethnicity of patients before and after the expansion of Medicaid under the Affordable Care Act.
Authors: Tristen S. Park, M.D., of the Yale University School of Medicine in New Haven, Connecticut, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
Patient and public voices were "regrettably" absent in the early stages of the covid-19 pandemic, but must now move centre stage, argue experts in The BMJ today.
Patient Partnership Editor Tessa Richards, Patient Editor Henry Sowcroft, and the members of The BMJs International Patient and Public Advisory Panel, acknowledge that decisions had to be made fast, but say "policy makers' choice of expert advisers excluded those with expertise rooted in lived experience - patients, families, and frontline health and social care professionals."
What The Study Did: Weekly changes in U.S. deaths from March 1 through May 30, 2020, due to any cause and deaths due to pneumonia, influenza or COVID-19 are investigated in this observational study.
Authors: Daniel M. Weinberger, Ph.D., of the Yale School of Public Health in New Haven, Connecticut, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamainternmed.2020.3391)
Major weaknesses exist in the evidence base for covid-19 antibody tests, finds a review of the latest research published by The BMJ today.
The evidence is particularly weak for point-of-care tests (performed directly with a patient, outside of a laboratory) and does not support their continued use, say the researchers.
Residents in all 25 of the U.S. counties hardest hit by COVID-19 began to limit their public movements six to 29 days before states implemented stay-at-home orders, according to Johns Hopkins University researchers.
The decline in the number of daily trips people made as tracked by mobile phone data helped slow the spread of the virus, according to findings published today in The Lancet Infectious Diseases journal from the Johns Hopkins team that created the world-famous online coronavirus tracking map.
Inhibit the specific activity of a protein affected by a mutation using high doses of a drug is the usual treatment for many cancers. Despite in the first instance this strategy is effective, leads to treatment resistance development by tumor cells through the appearance of secondary mutations, which enhance alternative growth pathways, and allow cells to avoid the effect of the drug. This is the case of non-small cell lung cancer (NSCLC), caused by mutations in the EGFR receptor, in which treatment with EGFR inhibitors leads to resistance.
LA JOLLA--(July 1, 2020) Chronic liver disease represents a major global public health problem affecting an estimated 844 million people, according to the World Health Organization. It is among the top causes of mortality in Australia, the UK and the United States. At the same time, it is both difficult to manage and there is no FDA-approved anti-fibrotic liver therapy. The microbiome--a complex collection of microbes that inhabit the gut--may be an unexpected indictor of health.
Sophia Antipolis - 1 July 2020: East Germany has many more hospitalisations for heart failure compared to West Germany despite a nationwide healthcare system, according to research presented today on HFA Discoveries, a scientific platform of the European Society of Cardiology (ESC).1